A detailed history of Iron Financial, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Iron Financial, LLC holds 2,252 shares of NVO stock, worth $239,004. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,252
Previous 2,296 1.92%
Holding current value
$239,004
Previous $327,000 18.04%
% of portfolio
0.15%
Previous 0.19%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$119.07 - $145.42 $5,239 - $6,398
-44 Reduced 1.92%
2,252 $268,000
Q2 2024

Jul 29, 2024

BUY
$122.71 - $146.91 $1,595 - $1,909
13 Added 0.57%
2,296 $327,000
Q1 2024

Apr 23, 2024

BUY
$102.11 - $135.92 $1,327 - $1,766
13 Added 0.57%
2,283 $293,000
Q4 2023

Jan 19, 2024

SELL
$87.78 - $105.45 $526 - $632
-6 Reduced 0.26%
2,270 $234,000
Q3 2023

Oct 31, 2023

BUY
$90.94 - $199.54 $206,979 - $454,153
2,276 New
2,276 $206,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $240B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Iron Financial, LLC Portfolio

Follow Iron Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iron Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iron Financial, LLC with notifications on news.